Cancer care is advancing at an extraordinary pace. New targeted treatments, immunotherapies, and personalized approaches are helping more patients live longer and fuller lives. These advances are bringing hope to those who once had few options.
At the same time, one of our greatest opportunities lies in preventing cancer when possible and detecting it at its earliest, most treatable stages. Through risk reduction, screening, improved treatment, critical research, and improved access to care, we can continue to lessen cancer’s impact.
We are encouraged by the progress we have made, but we also recognize that there is important work ahead. Alongside our patients, caregivers, researchers, clinicians, and supporters, we are committed to driving discovery and improving outcomes for everyone affected by cancer.
Sincerely,
Eric P. Winer, MD
Alfred Gilman Professor of Medicine and Pharmacology
Director, Yale Cancer Center
President and Physician-in-Chief, Smilow Cancer Hospital
Deputy Dean for Cancer Research, Yale School of Medicine